229 related articles for article (PubMed ID: 8511998)
21. [Use of BCG as an immunoadjuvant in combination with antitumor agents in virus-induced leukemia].
Sbaraglia G; Cenci E; Vecchiarelli A; Perito S
Boll Soc Ital Biol Sper; 1980 Oct; 56(19):1969-75. PubMed ID: 7459108
[TBL] [Abstract][Full Text] [Related]
22. [Pathogenesis of Rauscher leukemia in aggregation chimeras of the BALB/C----C57BL/6 mouse].
Fedorov LM; Klepikov NN; Koniukhov BV
Izv Akad Nauk SSSR Biol; 1986; (4):561-70. PubMed ID: 3745637
[No Abstract] [Full Text] [Related]
23. [Effects of organic fluorosilicone compounds on the development of tumors in mice].
Snegireva AE; Shaposhnikova GM; Ignatenko MA; Shevliagin VIa; Dobrynin IaV; Nikolaeva TG; Borovskiĭ IuV; Karabach OS
Biull Eksp Biol Med; 1990 Feb; 109(2):178-9. PubMed ID: 2337656
[TBL] [Abstract][Full Text] [Related]
24. A sequential multi-assay protocol for the preclinical assessment of natural product complex carbohydrate immunomodulators.
Williams DL; Pretus HA; McNamee RB; Jones EL
Dev Biol Stand; 1992; 77():129-36. PubMed ID: 1426653
[TBL] [Abstract][Full Text] [Related]
25. Antiviral efficacy of Imexon in the Rauscher murine retrovirus AIDS model.
Chirigos MA; Ussery MA; Rankin JT; Herrmann D; Bicker U; Black PL
Immunopharmacol Immunotoxicol; 1990; 12(1):1-21. PubMed ID: 1693633
[No Abstract] [Full Text] [Related]
26. The enhancing effect of sodium nitrite on virus-induced leukemia in mice.
Ilnitsky AP; Kolpakova AS
Cancer Detect Prev; 1997; 21(4):312-8. PubMed ID: 9232321
[TBL] [Abstract][Full Text] [Related]
27. Suramin has adjuvant properties and promotes expansion of antigen-specific Th1 and Th2 cells in vivo.
Denkinger M; Shive CL; Pantenburg B; Forsthuber TG
Int Immunopharmacol; 2004 Jan; 4(1):15-24. PubMed ID: 14975356
[TBL] [Abstract][Full Text] [Related]
28. [Hemopoiesis in Rauscher-leukemia and the influence of hypertransfusion (studies with Balb-c mice)].
Seidel HJ
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1972; 77(2):155-65. PubMed ID: 4260569
[No Abstract] [Full Text] [Related]
29. The in vitro growth of bone marrow cells from Rauscher leukemia virus infected mice.
van Griensven LJ; Hull E van't ; de Vries MJ
Biomedicine; 1973 Apr; 19(4):138-41. PubMed ID: 4731986
[No Abstract] [Full Text] [Related]
30. The in vitro growth of bone marrow cells from Rauscher leukemia virus infected mice.
van Griensven LJ; Hull EV; de Vries MJ
Biomedicine; 1973 Apr; 19(4):138-41. PubMed ID: 4715573
[No Abstract] [Full Text] [Related]
31. Colony forming unit suicide in normal and Rauscher leukemic mice given tritiated thymidine in vivo.
Okunewick JP; Phillips EL
Exp Hematol; 1974; 2(1):9-15. PubMed ID: 4455510
[No Abstract] [Full Text] [Related]
32. Erythrocyte production and survival in Rauscher murine leukemia virus-infected BABL/c mice.
de Both NJ; Kwak E; Klootwijk-van Dijke E
Cancer Res; 1980 Nov; 40(11):4270-5. PubMed ID: 7471066
[TBL] [Abstract][Full Text] [Related]
33. [Endogenous regulators of hematopoiesis and their role in the therapy of leukemias].
Svirnovskiĭ AI
Ter Arkh; 1988; 60(5):152-6. PubMed ID: 3051485
[No Abstract] [Full Text] [Related]
34. [Effect of folic acid and methotrexate on the reproduction of the Rauscher leukemia virus].
Shobukhov VM; Galegov GA
Biull Eksp Biol Med; 1974 Jul; 78(7):85-6. PubMed ID: 4451720
[No Abstract] [Full Text] [Related]
35. [On the pathodynamics of proliferative processes in the spleen of NMRI-mice during the early phase of Rauscher leukemia].
Komitowski D; Goerttler K
Exp Pathol (Jena); 1974; 9(3):182-90. PubMed ID: 4435093
[No Abstract] [Full Text] [Related]
36. Folic acid metabolism in Rauscher murine leukemia and effect of methotrexate on the blood picture.
Taguchi H; Sanada H
Acta Med Okayama; 1974 Oct; 28(5):353-9. PubMed ID: 4281996
[No Abstract] [Full Text] [Related]
37. [Ribonuclease polymorphism in experimental leukemia].
Shliakhovenko VA
Vestn Akad Med Nauk SSSR; 1973; 28(7):80-5. PubMed ID: 4522715
[No Abstract] [Full Text] [Related]
38. [Spontaneous regression of Rauscher leukemia in AKR line mice].
Tsysina EN; Irlin IS
Biull Eksp Biol Med; 1971 Dec; 72(12):68-71. PubMed ID: 5132140
[No Abstract] [Full Text] [Related]
39. BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.
Mathé G; Weiner R; Pouillart P; Schwarzenberg L; Jasmin C; Schneider M; Hayat M; Amiel JL; de Vassal F; Rosenfeld C
Natl Cancer Inst Monogr; 1973 Dec; 39():165-75. PubMed ID: 4595314
[No Abstract] [Full Text] [Related]
40. [Rauscher virus and Rauscher disease. 1. Peripheral blood picture with special reference to the appearance of Rauscher cells].
Irino S; Osato Y; Dabasaki H; Hiraki K
Igaku To Seibutsugaku; 1966 Jun; 72(6):305-9. PubMed ID: 6005888
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
